Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Dr Jeremy Schafer Discusses the Importance of Immunogenicity of Biosimilars
1:02
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Dr Jeremy Schafer Discusses the Importance of Immunogenicity of Biosimilars
1:02
|
Comment: Immunogenicity of biosimilars
1:28
|
The science of biosimilarity: Immunogenicity
5:29
|
Immunogenicity and Biosimilars
2:45
|
The Immunogenic Potential of Biosimilars: Should Health Care Providers Be Concerned?
2:29
|
Biosimilars - The Importance of In Vitro Assays for the Development of Biosimilars
8:57
|
What's Health Canada Saying about Biosimilars?
2:52
|
Biosimilars and the Issue of Interchangeability
4:53
|
What is a biosimilar? Biosimilars explained by a doctor and pharmacist
4:18
|
Bonnie Rup: Unwanted immunogenicity risk in biotherapeutic discovery and development
37:51
|
FDA: Celltrion’s Remicade Biosimilar “Highly Similar” To Branded Drug
2:25
|
From biologics to biosimilars: Current status and future challenges
4:05
|
Immunogenicity and Serum Levels Across IMIDs
20:26
|
"Biosimilars" by Prateek Mendiratta, MD & Indrani Kar, PharmD
56:23
|
Amy Rosenberg: You Think You've Mastered Immunity? Cautionary Tales from The Immunology Revolution
41:54
|
Kalveer Flora, MPharm: Patient Response to Switching to Biosimilar Adalimumab
1:09
|
Panel Discussion - IHE Biosimilars Forum
1:12:27
|
Biosimilar medicines, an opportunity for healthcare- Subtitles
3:41
|
Q&A with Miguel Regueiro: Hot Topics in IBD
4:35
|
Safety of Biologic Therapies
0:53
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
